Literature DB >> 2510897

Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit.

H S Cairns1, L D Fairbanks, J Westwick, G H Neild.   

Abstract

1. The endothelium releases a number of vasoactive compounds, including the vasodilator prostaglandins, prostacyclin (PGI2) and prostaglandin E2 (PGE2) and endothelium-derived relaxing factor (EDRF), which play an important role in the regulation of vascular tone in the microcirculation. Nephrotoxicity is the major complication of cyclosporin (CS) therapy and is related to an increase in intrarenal vascular tone. Endothelial cell generation of PGI2 is inhibited by CS although this cannot fully explain the changes in vascular tone observed. We have investigated the possibility that EDRF-dependent vasodilatation is also affected by CS therapy in vivo. 2. CS nephrotoxicity was induced in rabbits with CS (15 mg kg-1 per day s.c. for 20 days (n = 6]; 6 rabbits were given CS vehicle (Veh) and 9 animals were studied without any treatment. Creatinine clearance fell significantly during treatment in the CS-treated rabbits (11.78 +/- 1.5 ml min-1, mean +/- s.e. mean, to 7.79 +/- 1.2 after 20 days treatment) but did not change in the vehicle-treated animals. 3. The responses to the endothelium-dependent (acetylcholine (ACh] and endothelium-independent (nitroprusside (NP) and PGI2) vasodilators were assessed in indomethacin-treated isolated perfused kidneys (IPKs) from untreated, CS- and Veh-treated animals. Vascular tone was induced with a constant infusion of noradrenaline 150 nM and the perfusion rate adjusted to produce a perfusion pressure of 90 mmHg. Perfusate flow rate (22.3 +/- 4.6 vs 20.4 +/- 3.1 ml min-1) and glomerular filtration rate (2.04 +/- 0.37 vs 1.88 +/- 0.16 nl min-1) did not differ between IPKs from CS- and Veh-treated animals. 4. The vasodilator response to ACh was reduced in the kidneys from CS-treated animals compared with those from untreated and Veh-treated animals (mean reduction 35.3 + 2.3% compared with Veh) as were the responses to both NP (42.8 + 3.6%) and PGI2 (27.7 + 7.4%). 5. This suggests that CS nephrotoxicity is not mediated via an effect on endothelium-dependent responses and that it is more likely that CS has a direct effect on vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510897      PMCID: PMC1854705          DOI: 10.1111/j.1476-5381.1989.tb12619.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.

Authors:  C Smeesters; P Chaland; L Giroux; J M Moutquin; P Etienne; F Douglas; J Corman; G St-Louis; P Daloze
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

2.  Effect of cyclosporine A treatment on vascular reactivity of the rat thoracic aorta.

Authors:  A Rego; R Vargas; M L Foegh; P W Ramwell
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

3.  Cyclosporine inhibits prostacyclin production by cultured human endothelial cells.

Authors:  Z Brown; G H Neild
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

4.  Is arginine a physiological precursor of endothelium-derived nitric oxide?

Authors:  H H Schmidt; M M Klein; F Niroomand; E Böhme
Journal:  Eur J Pharmacol       Date:  1988-03-29       Impact factor: 4.432

5.  Effects of chronic cyclosporine therapy on renal vascular reactivity in the isolated perfused rabbit kidney.

Authors:  D O Monaco; R B Wait; A L Friedman; K U Kahng
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

6.  Sodium reabsorption in the perfused rat kidney.

Authors:  B D Ross; F H Epstein; A Leaf
Journal:  Am J Physiol       Date:  1973-11

7.  Indomethacin and aspirin abolish prostaglandin release from the spleen.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

8.  Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure.

Authors:  J D Conger; J B Robinette; R W Schrier
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Cyclosporine A enhances vasopressin-induced Ca2+ mobilization and contraction in mesangial cells.

Authors:  H Meyer-Lehnert; R W Schrier
Journal:  Kidney Int       Date:  1988-07       Impact factor: 10.612

10.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

View more
  2 in total

Review 1.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Beneficial effect of amrinone on murine cardiac allograft survival.

Authors:  T Hirozane; A Matsumori; Y Furukawa; S Matsui; Y Sato; Y Matoba; S Sasayama
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.